Overview: Amylase Serum TestIntroduction: The Amylase Serum Test measures amylase in blood to diagnose pancreatic disorders like pancreatitis, which may cause severe abdominal pain or nausea. Aligned with 2023 AGA guidelines, it uses spectrophotometry for high accuracy, aiding in metabolic screening. This test is critical for guiding treatment, monitoring pancreatic function, and improving outcomes in biochemistry for patients with suspected pancreatic issues.
Other Names: Serum Amylase Assay, Pancreatic Amylase Blood Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Amylase testing began in the 1950s with serum assays. Spectrophotometric methods emerged in the 1970s, and by the 2000s, high-sensitivity assays improved diagnostic precision.
Purpose: Diagnoses pancreatic disorders, guides treatment, and monitors pancreatic function in patients with abdominal pain or nausea.
Test Parameters: 1. Amylase
Pretest Condition: Fasting for 10-12 hours required to stabilize enzyme levels. Collect serum or plasma after overnight fasting. Report symptoms like abdominal pain or nausea, and list medications like painkillers.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document pancreatic symptoms, alcohol use, or family history of pancreatic disorders. Include current medications, especially those affecting pancreatic function.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for imaging or treatment.
Procedural Considerations: Uses spectrophotometry to measure serum amylase levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting samples or recent alcohol consumption may alter results. Hemolysis or improper storage can degrade samples.
Clinical Significance: Elevated serum amylase levels suggest pancreatitis, prompting imaging or treatment. Normal levels may require lipase testing for confirmation.
Specialist Consultation: Consult a gastroenterologist for result interpretation. A pancreatic specialist referral is advised for confirmed cases.
Additional Supporting Tests: Lipase test, abdominal imaging, or amylase isoenzymes test to confirm pancreatitis or assess pancreatic damage.
Test Limitations: False positives may occur with salivary gland issues or kidney dysfunction. Results require clinical correlation.
References: AGA Pancreatitis Guidelines, 2023; Gastroenterology, Whitcomb DC, 2022.
